CN Patent

CN116693449A — 用作tyk2抑制剂的化合物、其制备方法及其在医药上的应用

Assigned to Shanghai Zhigen Pharmaceutical Technology Co ltd · Expires 2023-09-05 · 3y expired

What this patent protects

本发明涉及用作TYK2抑制剂的化合物、其制备方法及其在医药上的应用。具体地，本发明化合物具有式(I)所示结构，其中各基团和取代基的定义如说明书中所述。本发明还公开了所述化合物的制备方法及其在预防和/或治疗由TYK2介导相关疾病方面的用途。

USPTO Abstract

本发明涉及用作TYK2抑制剂的化合物、其制备方法及其在医药上的应用。具体地，本发明化合物具有式(I)所示结构，其中各基团和取代基的定义如说明书中所述。本发明还公开了所述化合物的制备方法及其在预防和/或治疗由TYK2介导相关疾病方面的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN116693449A
Jurisdiction
CN
Classification
—
Expires
2023-09-05
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Zhigen Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.